MedPath

Trial of Ultrasound Guided Femoral Nerve Block on Isolated Femur Fracture Using Echo Friendly Needles

Phase 4
Terminated
Conditions
Pain
Interventions
Drug: Femoral Nerve Block
Device: Standard of care needle
Device: Echogenic needle
Device: Ultrasound
Registration Number
NCT02046317
Lead Sponsor
The University of Texas Health Science Center, Houston
Brief Summary

This study aims to determine if there is any difference in the success rate of ultra-sound guided femoral nerve block performed with an echogenic needle versus a standard needle.

Detailed Description

To date, the published information regarding ultrasound guided femoral nerve blocks (FNB) using echo friendly needle is very limited. More so, there is even less information regarding ultrasound guided nerve blocks using echogenic versus standard of care needles.

This study hopes to add to the general knowledge of pain management in the emergency department (ED) setting and provide a unique perspective on ultrasound-guided techniques using echogenic needles to enhance accuracy and success rate of nerve blocks in ED patients.

The study design will have two comparative arms; in both arms we use the same local anesthetic which is Bupivacaine 0.25% with epinephrine; in all cases a total of 15 mL will be injected around the femoral nerve. Once identified with ultrasound, 5 ml will be injected at lateral, medial, and posterior aspect of the nerve. The experimental arm will receive an FNB using an echogenic needle; and the control group will receive an FNB using standard of care needles.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
12
Inclusion Criteria
  • Patients who present to the emergency department (ED) with isolated femur fracture (no other injuries)
  • Patients who are cognitively alert and are able to verbalize their pain using a visual analog scale (VAS)
  • Patients who are mentally competent to consent for the study
  • Patients who can communicate in English or Spanish
Exclusion Criteria
  • Gestation
  • Prisoners
  • Patients who cannot communicate in English or in Spanish
  • Patients who have other significant injuries besides a femur fracture
  • Patients who are cognitively impaired and/or unable to verbalize their pain using a visual analog scale (VAS)
  • Patients with allergies to local anesthetics
  • Patients with severe liver disease
  • Patients with existing peripheral neuropathies in the affected limb
  • Patients with history of complications from previous femoral blocks
  • Patients with contraindications for needle insertion at inguinal area
  • Local signs of infection
  • Patient on anticoagulants and/or with history of coagulation disorders

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Standard of care needleStandard of care needleThe control group will receive ultrasound-guided femoral nerve block using standard of care needles.
Echogenic needleEchogenic needleThe experimental arm will receive ultrasound-guided femoral nerve block using echogenic needles, which are micro laser etched near the tip to reflect sound waves back to the transducer and make the tip visible.
Echogenic needleUltrasoundThe experimental arm will receive ultrasound-guided femoral nerve block using echogenic needles, which are micro laser etched near the tip to reflect sound waves back to the transducer and make the tip visible.
Echogenic needleFemoral Nerve BlockThe experimental arm will receive ultrasound-guided femoral nerve block using echogenic needles, which are micro laser etched near the tip to reflect sound waves back to the transducer and make the tip visible.
Standard of care needleFemoral Nerve BlockThe control group will receive ultrasound-guided femoral nerve block using standard of care needles.
Standard of care needleUltrasoundThe control group will receive ultrasound-guided femoral nerve block using standard of care needles.
Primary Outcome Measures
NameTimeMethod
Patient Pain Level60 minutes after initial femoral block

Pain level will be measured on a numeric visual analogue scale of 0-10 with 0 being no pain and 10 being the worst pain ever.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Lyndon Baines Johnson General Hospital

🇺🇸

Houston, Texas, United States

Memorial Hermann Hospital Texas Medical Center

🇺🇸

Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath